Ireland
--:--IST
Recruiting Not applicable

Efficacy of Intensive Visual Simulation (IVS) Before Exoskeleton-assisted Step Training in Patients With Hemisensory Syndrome With Brain Injury of Vascular Etiology.

NCT07860840 · tracked via the Priya Life Science Italy tracker
Phase
Not applicable
Started
2024-04-21
Last updated
2026-10-06

Condition(s) studied

Exoskeleton DeviceSensory DisorderBrain Injuries, Vascular

Investigational drug(s) / intervention(s)

Rehabilitation treatment with IVS before step training using an exoskeletonRehabilitation treatment with step training using an exoskeleton

Rehabilitation treatment with IVS before step training using an exoskeleton: * 15 minutes of IVS: The physical therapist will show the patient a pre-recorded sequence of movements and activities involving the lower limb. Patient will observe the movements on a screen positioned to cover the paretic limb and will then be ask to repeat them. * 30 minutes of EKSO training:The physical therapist will set up the training using a single program defined as "assistive" to observe the degree of dependence on the machine throughout the course of treatment and will maintain this setting for all sessions, documenting the percentage changes in the level of assistance required. * 45 minutes of non-robotic motor therapy following the robotic treatment. The physical therapist will perform motor treatments involving mobilization, muscle strengthening, and standing with the goal of improving the patient's ability to perform transfers and maintain an upright position independently. The rehabilitation treatment session will be repeated 5 days a week for 3 weeks.

Rehabilitation treatment with step training using an exoskeleton: * 30 minutes of EKSO training: The physical therapist will set up the training using a single program defined as "assistive" to observe the degree of dependence on the machine throughout the course of treatment and will maintain this setting for all sessions, documenting the percentage changes in the level of assistance required. * 45 minutes of non-robotic motor therapy following the robotic treatment. The physical therapist will perform motor treatments involving mobilization, muscle strengthening, and standing with the goal of improving the patient's ability to perform transfers and maintain an upright position independently. The rehabilitation treatment session will be repeated 5 days a week for 3 weeks.

Study summary

Clinical trial involving a medical device, not intended for CE marking, randomized, blinded to evaluate the efficacy of preparatory treatment with Intensive Visual Simulation 4 (IVS) prior to exoskeleton-assisted (EKSO) step training in achieving independent ambulation in hemiparetic patients with impaired proprioceptive sensation. Patients will be randomized into two groups: one group in which patients will undergo IVS treatment before physiotherapy and robotic step training with an exoskeleton; and one group in which patients will undergo only physiotherapy and robotic step training with an exoskeleton.

Eligibility

Sex
ALL
Min age
18 Years
Max age
80 Years
Healthy volunteers
No
Inclusion Criteria: * Male and female patients aged 18 to 80 years (both ends included). * Diagnosis of hemiparesis/plegia with proprioceptive sensory deficit due to a cerebrovascular event within the last 6 months * Orientation in the 3 domains (space, time, and person) * Cooperation * Clinical stability * Trunk control while standing * Signature of the Informed Consent Form for participation in the study and for the processing of personal data Exclusion Criteria: * Patients aged \< 18 years and \> 80 years * Patients who are disoriented in at least one of the three domains (space, time, and person) * Non-cooperative patients * Patients with global aphasia * Patients with severe ideomotor apraxia * Patients with cognitive or mental disorders * Patients not eligible for EKSO: * Severe comorbid conditions: infections, circulatory, cardiac, or pulmonary diseases, pressure ulcers. * Severe spasticity (level 4 on the modified Ashworth scale). * Spinal instability or unhealed fractures of the limbs or pelvis. * Heterotopic ossification. * Psychiatric or cognitive conditions that may interfere with the proper use of the device. * Pregnant women. * Reduced tolerance for standing due to orthostatic hypotension. * Range of motion (ROM) limitations that would prevent the patient from achieving a normal bilateral gait pattern or performing normal transitions from a seated to a standing position and vice versa: Bilateral hip flexion less than 110°, knee flexion contracture greater than 12°, or inability to achieve neutral dorsiflexion of 0° with knee flexion up to 12°. * Leg length discrepancy greater than 1.27 cm for the upper leg and 1.9 cm for the lower leg. * Unresolved deep vein thrombosis. * Uncontrolled autonomic dysreflexia. * Lower limb prostheses.

Primary outcome measure(s)

  • Efficacy of preparatory treatment with Intensive Visual Simulation (IVS) for step training with an exoskeleton (EKSO) — Baseline to Timepoint 1 (3 weeks after)
    Scores on the Berg Balance Scale from baseline to the end of treatment. The scale assesses static and minimal dynamic balance, as well as the risk of falling. The score ranges from 0 to 56.
  • Efficacy of preparatory treatment with Intensive Visual Simulation (IVS) for step training with an exoskeleton (EKSO) — Baseline to Timepoint 1 (3 weeks after)
    Scores on the Timed Up and Go test from baseline to the end of treatment. The test measures, in seconds, the time it takes a patient to stand up from a chair with armrests, walk 3 meters, turn around, walk back, and sit down again.

Trial sites (1)

FacilityCityRegionStatus
IRCCS Sacro Cuore Don Calabria Hospital Negrar Italy Recruiting
Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT07860840 on ClinicalTrials.gov ↗ ← All trials in Italy